{"id":"ambroxol-hydrochloride-420mg","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances (nausea, diarrhea)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Rash or allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ambroxol works by stimulating serous cells in the respiratory tract to increase mucus secretion while simultaneously reducing mucopolysaccharide chains, thereby decreasing mucus viscosity and elasticity. This dual action improves mucociliary clearance and makes expectoration easier. It may also have anti-inflammatory and antioxidant properties that support respiratory health.","oneSentence":"Ambroxol is a mucolytic agent that breaks down and reduces the viscosity of respiratory mucus, facilitating clearance from the airways.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:01:09.061Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute and chronic bronchitis"},{"name":"Bronchiectasis"},{"name":"Asthma with mucus hypersecretion"},{"name":"Cystic fibrosis (investigational)"}]},"trialDetails":[{"nctId":"NCT05778617","phase":"PHASE3","title":"Ambroxol to Slow Progression in Parkinson Disease","status":"RECRUITING","sponsor":"University College, London","startDate":"2025-02-25","conditions":"Parkinson Disease","enrollment":330}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Ambroxol"],"phase":"phase_3","status":"active","brandName":"Ambroxol Hydrochloride (420mg)","genericName":"Ambroxol Hydrochloride (420mg)","companyName":"University College, London","companyId":"university-college-london","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ambroxol is a mucolytic agent that breaks down and reduces the viscosity of respiratory mucus, facilitating clearance from the airways. Used for Acute and chronic bronchitis, Bronchiectasis, Asthma with mucus hypersecretion.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}